Polar Asset Management Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Polar Asset Management Partners’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,731	Closed	-$117K	–	1112
2023 Q1	$117K	Hold	31,731	–	–	﹤0.01%	678
2022 Q4	$121K	Hold	31,731	–	–	﹤0.01%	795
2022 Q3	$251K	Hold	31,731	–	–	﹤0.01%	841
2022 Q2	$666K	Hold	31,731	–	–	0.01%	787
2022 Q1	$1.19M	Hold	31,731	–	–	0.01%	673
2021 Q4	$1.78M	Hold	31,731	–	–	0.02%	631
2021 Q3	$2.29M	Hold	31,731	–	–	0.02%	546
2021 Q2	$3.04M	Hold	31,731	–	–	0.03%	489
2021 Q1	$4.69M	Buy	+31,731	New	+$5.75M	0.05%	367

Other funds holding NBSE

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $78.9M AUM 38.67% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Polar Asset Management Partners's NBSE Position: Q2 2023 in Review

Polar Asset Management Partners sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2023, closing a stake of 31,731 shares — an estimated $117K sold.

Polar Asset Management Partners first reported a position in NBSE in Q1 2021 and held it in 9 quarters. The position peaked at $4.69M in Q1 2021. 27 funds tracked by Wall St. Rank hold NBSE as of Q2 2023.

Polar Asset Management Partners reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Polar Asset Management Partners sold 31,731 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $117K.
Polar Asset Management Partners first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Polar Asset Management Partners's NeuBase Therapeutics, Inc. Common Stock position peaked at $4.69M in Q1 2021.
27 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Polar Asset Management Partners's 13F filing for Q2 2023, filed 14 Aug 2023.